Unlikely to cause harm — often a labeling or packaging issue.
Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect lot number, 327B160012, appears on the case label, the correct lot number, 327B16002 appears on the immediate container.
| Brand name | IRBESARTAN AND HYDROCHLOROTHIAZIDE |
| Generic name | IRBESARTAN AND HYDROCHLOROTHIAZIDE |
| Active ingredient(s) | HYDROCHLOROTHIAZIDE, IRBESARTAN |
| Distributed by / for | Solco Healthcare U.S., LLC, Cranbury, NJ 08512 |
| NDC | 43547-331-09 |
| Full product label | Irbesartan and Hydrochlorothiazide Tablets, USP, 300/12.5 mg, Rx only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China; Distributed by: Solco Healthcare U.S., LLC, Cranbury, NJ 08512, NDC 43547-331-09. |
| Recalling firm | Prinston Pharmaceutical Inc |
| Distribution | Nationwide |
| Quantity | 60 bottles (5 cases) |
| Recall initiated | 2016-05-30 |
| Report date | 2016-06-29 |
| Recall completed | 2017-06-09 |
| Recall number | D-1049-2016 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Cranbury NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗